The Importance of Measuring Troponin in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review.
cardiac troponin
cardiac troponin i
copd exacerbation
copd: chronic obstructive pulmonary disease
elevated troponin
obstructive lung diseases
pulmonary and cardiac pathophysiology
pulmonary exacerbation
serum biomarkers
smoking tobacco
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
21
06
2021
accepted:
26
08
2021
entrez:
4
10
2021
pubmed:
5
10
2021
medline:
5
10
2021
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Many patients with acute exacerbations need intensive care. There are many cardiovascular risk factors and comorbid conditions linked with COPD. Troponin elevation is used for the diagnosis of myocardial infarction. However, it is commonly elevated in patients with COPD. This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed and Scopus were searched for relevant articles. A total of 383 papers were identified. Out of the 383 papers, only 30 papers remained for final synthesis after removing duplicates, screening for relevant articles, and assessing eligibility criteria. After the quality appraisal, 11 papers were chosen for inclusion in this study. COPD is characterized by obstruction and inflammation of the airways. It is caused mainly by smoking, by causing harmful changes in the structure of the airways. It usually presents with dyspnea, cough, and/or production of sputum. Troponins are regulatory proteins found in the myocardium and skeletal muscles. The cause of its elevation in COPD and acute exacerbated chronic obstructive pulmonary disease (AECOPD) remains unclear. However, several reasons and factors have been suggested. The most intriguing fact is that high troponin in COPD, especially in exacerbations, has been linked in many articles to a higher risk of death. Furthermore, it could serve as a tool for better assessment and management of COPD patients. We found that troponin predicts death and poor outcomes in COPD and AECOPD. The exact mechanism of its elevations is not clear. We believe it can be a valuable tool for clinicians in better managing COPD and assessing the severity of the exacerbations.
Identifiants
pubmed: 34603857
doi: 10.7759/cureus.17451
pmc: PMC8475747
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e17451Informations de copyright
Copyright © 2021, Elmenawi et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pulmonology. 2019 May - Jun;25(3):168-176
pubmed: 30527374
Intern Med J. 2019 Jun;49(6):761-769
pubmed: 30324703
Eur Respir J. 2008 Mar;31(3):563-70
pubmed: 18032444
Lung India. 2016 Jan-Feb;33(1):53-7
pubmed: 26933308
BMC Pulm Med. 2016 Nov 25;16(1):164
pubmed: 27887619
Emerg Med Australas. 2004 Jun;16(3):212-5
pubmed: 15228464
Open Heart. 2015 Mar 26;2(1):e000052
pubmed: 25852947
Heart. 2013 Jan;99(2):122-6
pubmed: 23024006
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Acta Med Indones. 2013 Jul;45(3):240-50
pubmed: 24045397
Open Heart. 2014 Jan 15;1(1):e000001
pubmed: 25332772
J Am Coll Cardiol. 2018 Sep 4;72(10):1126-1137
pubmed: 30165984
Eur J Emerg Med. 2013 Feb;20(1):54-7
pubmed: 22495355
Am Health Drug Benefits. 2008 Sep;1(7):34-42
pubmed: 25126252
Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:289-299
pubmed: 33603355
J Clin Pathol. 2004 Oct;57(10):1025-6
pubmed: 15452153
J Thorac Dis. 2019 Oct;11(Suppl 17):S2129-S2140
pubmed: 31737341
Intern Emerg Med. 2014 Apr;9(3):335-9
pubmed: 24326466
Arch Intern Med. 2007 Feb 12;167(3):276-81
pubmed: 17296884
Thorax. 2011 Sep;66(9):775-81
pubmed: 21653926
Respir Med. 2018 Dec;145:192-199
pubmed: 30509708
Am J Respir Crit Care Med. 2006 Nov 1;174(9):990-6
pubmed: 16840745
BMC Pulm Med. 2009 Jul 19;9:35
pubmed: 19615100